These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 15507105

  • 1. Androgen action on human skin -- from basic research to clinical significance.
    Zouboulis CC, Degitz K.
    Exp Dermatol; 2004; 13 Suppl 4():5-10. PubMed ID: 15507105
    [Abstract] [Full Text] [Related]

  • 2. Sexual hormones in human skin.
    Zouboulis CC, Chen WC, Thornton MJ, Qin K, Rosenfield R.
    Horm Metab Res; 2007 Feb; 39(2):85-95. PubMed ID: 17326004
    [Abstract] [Full Text] [Related]

  • 3. Managing cutaneous manifestations of hyperandrogenic disorders: the role of oral contraceptives.
    Wiegratz I, Kuhl H.
    Treat Endocrinol; 2002 Feb; 1(6):372-86. PubMed ID: 15832490
    [Abstract] [Full Text] [Related]

  • 4. Dermatology of androgen-related disorders.
    Essah PA, Wickham EP, Nunley JR, Nestler JE.
    Clin Dermatol; 2006 Feb; 24(4):289-98. PubMed ID: 16828411
    [Abstract] [Full Text] [Related]

  • 5. [Hyperandrogenism and pilosebaceous follicles].
    Verschoore M.
    Rev Prat; 1993 Nov 15; 43(18):2363-9. PubMed ID: 8128156
    [Abstract] [Full Text] [Related]

  • 6. [Clinical significance of testosterone and dihydrotestosterone metabolism in women].
    Korsić M.
    Lijec Vjesn; 1996 Mar 15; 118 Suppl 1():21-3. PubMed ID: 8759403
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Androgens in women: Androgen-mediated skin disease and patient evaluation.
    Bienenfeld A, Azarchi S, Lo Sicco K, Marchbein S, Shapiro J, Nagler AR.
    J Am Acad Dermatol; 2019 Jun 15; 80(6):1497-1506. PubMed ID: 30312644
    [Abstract] [Full Text] [Related]

  • 9. Androgen physiology and the cutaneous pilosebaceous unit.
    Mercurio MG, Gogstetter DS.
    J Gend Specif Med; 2000 Jun 15; 3(4):59-64. PubMed ID: 11253232
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of 5α-reductase inhibitors in androgen-stimulated skin disorders.
    Azzouni F, Zeitouni N, Mohler J.
    J Drugs Dermatol; 2013 Feb 15; 12(2):e30-5. PubMed ID: 23377402
    [Abstract] [Full Text] [Related]

  • 12. Nuclear and cytosol androgen receptor in androgen dependent dermatoses in female patients.
    Schmidt JB.
    Exp Clin Endocrinol; 1987 Aug 15; 90(1):107-12. PubMed ID: 2959494
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The hormonal regulation of cutaneous wound healing.
    Gilliver SC, Ashworth JJ, Ashcroft GS.
    Clin Dermatol; 2007 Aug 15; 25(1):56-62. PubMed ID: 17276202
    [Abstract] [Full Text] [Related]

  • 15. Androgens and ageing of the skin.
    Makrantonaki E, Zouboulis CC.
    Curr Opin Endocrinol Diabetes Obes; 2009 Jun 15; 16(3):240-5. PubMed ID: 19390323
    [Abstract] [Full Text] [Related]

  • 16. The influence of sex hormones on acne.
    Förström L.
    Acta Derm Venereol Suppl (Stockh); 1980 Jun 15; Suppl 89():27-31. PubMed ID: 6258368
    [Abstract] [Full Text] [Related]

  • 17. Acne: effect of hormones on pathogenesis and management.
    Shaw JC.
    Am J Clin Dermatol; 2002 Jun 15; 3(8):571-8. PubMed ID: 12358558
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Acne and hormones].
    Faure M.
    Rev Prat; 2002 Apr 15; 52(8):850-3. PubMed ID: 12053793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.